Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing

Rentschler Biopharma SE's CEO Frank Mathias, Ph.D. explains how the company develops best-fit solutions for complex client challenges to face the future of biopharmaceuticals.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: